Company / Capital Returned to Shareholders
Illumina, Inc. Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$742.0M
FY2025
5-year range
$0 / $742.0M
FY2021-FY2025
Trend
+539.7%
vs FY2024
Sector context
#28 of 108
Health Care
What the data says
Capital Returned to Shareholders changed +540% YoY in FY2025, a notable deviation from the 7-year average annual change of +76%.
Based on SEC 10-K filings.
$742M in FY2025 with a 5-year CAGR of +0.2%.
Improved from $0 to $742M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +0.3%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 26% of 108This company $742.0M Sector average $744.4M
▼
In line with sector average
Key checks
Key Insights
- 5-year CAGR of +0.2%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 539.7% year-over-year.
- Ranks #28 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $742.0M | +539.7% |
| FY2024 | $116.0M | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $736.0M | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $736.0M | +193.2% |
| FY2019 | $251.0M | +0.8% |
| FY2018 | $249.0M | -9.1% |
| FY2017 | $274.0M | +10.0% |
| FY2016 | $249.0M | -9.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026